Ridgeline therapeutics rt-002
WebDec 19, 2024 · Ridgeline Therapeutics. Oct 2024 - Present1 year 7 months. Houston, Texas, United States. I am currently: •Managing preclinical efficacy studies and performing their data analysis. •Helping to ... WebDec 4, 2024 · Source: Revance Therapeutics, Inc. INVESTORS Revance Therapeutics, Inc.: Jeanie Herbert 714-325-3584 [email protected]. Burns McClellan, Inc.: Ami Bavishi 212-213-0006 [email protected]. MEDIA General Media: TOGORUN: Mariann Caprino 917-242-1087 [email protected]. Trade Media: Nadine Tosk 504-453-8344 …
Ridgeline therapeutics rt-002
Did you know?
WebRidgeline Therapeutics AG Hochbergerstrasse 60C 4057 Basel Switzerland Ridgeline is Versant’s newest discovery engine and has laboratories in Basel Technology Park. Ridgeline’s leadership team hails from Roche and has a proven track record in drug development. [email protected] ridgelinediscovery.com Click here to send a … http://www.ridgelinetherapeutics.com/
WebMar 6, 2024 · Ridgeline Therapeutics is based in the Texas Medical Center. Watowich explains that 98 percent of biotech companies fail, so it's his goal to "stay lean" and use the $4.2 million award the company received from the Department of Defense to get their technologies into human trials. The company will likely move to the Johnson & Johnson … WebRidgeline Therapeutics Nov 2024 - Present 1 year 6 months. Houston, Texas, United States Doctoral Candidate The University of Texas at San Antonio Aug 2016 - Nov 2024 5 years 4 months. San Antonio ...
WebRT-002 is under development for the treatment of spasmodic torticollis (cervical dystonia), upper limb spasticity voice disorders, spasmodic dysphonia in after stroke or traumatic brain injury. It is administered by intramuscular route and a unspecified indication. WebJan 2, 2024 · RT-002 is under development for the treatment of spasmodic torticollis (cervical dystonia), upper limb spasticity voice disorders, spasmodic dysphonia in after …
WebSep 30, 2024 · To further derisk our lead candidates as potential therapeutics to greatly improve muscle growth, mass, and function in aged individuals, this Phase 1 project will complete (1) dose-ranging efficacy studies in aged animals to demonstrate proof-of-principal for our drug candidates to improve muscle growth and function, and (2) in vivo …
WebRidgeline Therapeutics is a biotechnology company engaged in drug discovery. It is focused on developing drugs to cure diabetes, obesity, muscular dystrophies, and sarcopenia (age-related muscle degeneration). Type Private Status Active Founded 2012 HQ West University Place, TX, US view all locations lab officesWebOct 30, 2024 · Duchenne Muscular Dystrophy - Pipeline Review, H2 2024, provides comprehensive information on the therapeutics under development for Duchenne Muscular Dystrophy (Genetic Disorders), complete with... lab ofichemWebMilford is a borough in Pike County, Pennsylvania, United States. The population was 1,104 at the 2000 census. It is the county seat of Pike County. It is served by the Delaware Valley … projecting filmWebDrug and Alcohol Addiction Treatment Center is now open at our New Milford Office! Location: 17382 State Route 11, Suite 3 New Milford, PA 18834 projecting financial statementshttp://www.ridgelinetherapeutics.com/news.html projecting fire exit signWebNov 20, 2024 · The company's lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines, cervical dystonia and plantar fasciitis with the potential to be the first long-acting neuromodulator. projecting for this pcWebRidgeline Therapeutics contact info: Phone number: +41 612254600 Website: www.ridgelinediscovery.com What does Ridgeline Therapeutics do? Ridgeline, a Versant Ventures Discovery Engine, was founded in early 2024 to create and operate Versant-financed innovative biotech companies in Basel, Switzerland. projecting financials for business plans